SCHEMBL402912

SCHEMBL402912

C=CC(=O)OCCOC(=O)CCCCCOC(=O)CCCCCO

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.63
ALDH1A1 P00352 4/20 0.63
CYP3A4 P08684 2/20 0.63
HPGD P15428 1/20 0.49
TP53 P04637 3/20 0.48
HIF1A Q16665 3/20 0.48
HSD17B10 Q99714 1/20 0.48
DGKA P23743 1/20 0.46
THRB P10828 2/20 0.41
PRSS1 P07477 1/20 0.38
PRSS2 P07478 1/20 0.38
PRSS3 P35030 1/20 0.38
APP P05067 2/20 0.38
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GAA P10253 1/20 0.37
EPHX2 P34913 1/20 0.36
DNM1 Q05193 1/20 0.36
GPR84 Q9NQS5 1/20 0.35
FFAR1 O14842 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18100189 1.00 TSHR (0.63) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL1054402 0.97 TSHR (0.57) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL276446 0.93 TSHR (0.73) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL16687526 0.92 TSHR (0.58) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL6676002 0.92 TSHR (0.66) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL11233083 0.91 TSHR (0.76) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL16744245 0.91 TSHR (0.56) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL25822792 0.90 TSHR (0.61) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL19165635 0.89 TSHR (0.65) TSHRALDH1A1CYP3A4HPGDTP53
SCHEMBL19627098 0.89 TSHR (0.65) TSHRALDH1A1CYP3A4HPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114231158-A Composition for high-precision anti-dazzle coating and high-precision anti-dazzle film thereof 惠州合益创光学材料有限公司 2022-03-25 CN claimed
US-11735737-B2 Binder for electricity storage devices improving dispersibility of conductive assistant FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2023-08-22 US disclosed
CN-114369439-B Toughening type photo-curable adhesive, and preparation method and application thereof 天津久日新材料股份有限公司 2023-08-01 CN disclosed
EP-2980058-B1 COMPOSITION CONTAINING VINYL-GROUP-CONTAINING COMPOUND TOKYO OHKA KOGYO CO LTD (JP) 2023-05-03 EP disclosed
US-11261288-B2 Allyl functional urethane oligomers and related compositions for coatings and adhesives ARKEMA FRANCE (FR) 2022-03-01 US disclosed
US-20200392280-A1 ALLYL FUNCTIONAL URETHANE OLIGOMERS AND RELATED COMPOSITIONS FOR COATINGS AND ADHESIVES ARKEMA FRANCE (FR) 2020-12-17 US disclosed
WO-2019036887-A1 ALLYL FUNCTIONAL URETHANE OLIGOMERS AND RELATED COMPOSITIONS FOR COATINGS, AND ADHESIVES ARKEMA FRANCE (FR) 2019-02-28 WO disclosed
US-9932428-B2 Thermoplastic resin composition and molding product made therefrom CHI MEI CORPORATION (TW) 2018-04-03 US disclosed
US-9932428-B2 Thermoplastic resin composition and molding product made therefrom CHI MEI CORPORATION (TW) 2018-04-03 US disclosed
US-20170210922-A1 3D PRINTING SYSTEM COMPRISING SOLID BUILD INK COMPRISING COLORANT XEROX CORPORATION 2017-07-27 US disclosed
US-20110074895-A1 CURABLE GEL INKS WITH REDUCED SYNERESIS AND HALO FORMATION XEROX CORPORATION (US) 2011-03-31 US disclosed
US-7905948-B2 Phase change ink compositions XEROX CORPORATION (US) 2011-03-15 US disclosed
US-20110053116-A1 DENTAL COMPOSITION CONTAINING A POLYFUNCTIONAL (METH)ACRYLATE COMPRISING URETHANE, UREA OR AMIDE GROUPS, METHOD OF PRODUCTION AND USE THEREOF SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2011-03-03 US disclosed
WO-2009090425-A1 FLUSHING COMPOSITION SERICOL LIMITED (GB) 2009-07-23 WO disclosed
US-20090076198-A1 Functionalized nanoparticles CIBA CORPORATION 2009-03-19 US disclosed
US-20090076198-A1 Functionalized nanoparticles CIBA CORPORATION 2009-03-19 US disclosed
EP-2028228-A2 Functionalized nanoparticles Ciba Holding Inc. (CH) 2009-02-25 EP disclosed
EP-1268357-B1 OPTICAL FIBERS PREPARED WITH A PRIMARY COATING COMPOSITION INCLUDING A MONOMER WITH A PENDANT HYDROXYL FUNCTIONAL GROUP CORNING INC (US) 2008-01-09 EP disclosed
US-7288591-B2 Curable dispersants 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-10-30 US disclosed
WO-2007060125-A1 REACTIVE SILICON OXIDE FLAKES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2007-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053116-A1 DENTAL COMPOSITION CONTAINING A POLYFUNCTIONAL (METH)ACRYLATE COMPRISING URETHANE, UREA OR AMIDE GROUPS, METHOD OF PRODUCTION AND USE THEREOF MUS81, MAT1A, SMCHD1 TSHR 3008/4885ALDH1A1 239/4885CYP3A4 2367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.